• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care
Rare Disease : Episode 5

Episode 5 - Current Therapeutic Strategies for Hemophilia

Video

Systemic lupus erythematosus (SLE) is a complex autoimmune process with the potential to detrimentally impact every organ system in the human body. According to Dr. Michelle Petri, up to two-thirds of SLE cases are due to genetic predisposition, with SLE being more prevalent and severe among African- and Hispanic-Americans. The remaining one-third of cases may be attributed to environmental and hormonal components, with women being affected more than men in a 9:1 ratio. The implications of SLE are far-reaching, and it is important to develop a greater understanding of the disease to further improve current diagnostic and management strategies.

Related Videos
William Schpero, PhD, MPhil, MPH
Jonathan Strober, MD, Benioff Children's Hospital
Jasmine Eugene, PharmD
Danielle Roman, PharmD, BCOP, Allegheny Health Network
Rebecca Spain, MD
Related Content
Doctor handing pills to patient | Image credit: joyfotoliakid – stock.adobe.com

Real-World Risks of Mavacamten Use for Obstructive Hypertrophic Cardiomyopathy

November 26th 2025
Article

After 8 months of treatment with mavacamten, 5% of patients developed new atrial fibrillation or flutter and 4% developed heart failure.

Read More

managed care cast logo

Home Health Care Delivery, Outcomes Vary by Payment Model: Rachel A. Prusynski, DPT, PhD

November 18th 2025
Podcast

Rachel A. Prusynski, DPT, PhD, discusses her study on how payment models affect home health care delivery and patient outcomes.

Listen

ACA subsidies and key CMS payment models end in 2025, pushing premiums higher and shifting costs to employers and consumers. | Image Credit: @DoubletreeStudio-AdobeStock.jpeg

Expiring ACA Subsidies and CMS Payment Models Raise Costs for Consumers and Employers

November 25th 2025
Article

With ACA subsidies and key CMS payment models ending in 2025, premiums are set to rise, shifting costs to consumers and employers.

Read More

Inside the Discovery That Changed CML Treatment Forever with Jorge Cortes, MD

Inside the Discovery That Changed CML Treatment Forever with Jorge Cortes, MD

November 11th 2025
Podcast

Lead CML researcher discusses the evolution of a groundbreaking treatment and its effect on patient survival.

Listen

FDA approval. | Image credit: aznan – stock.adobe.com

FDA Approves Gene Therapy Onasemnogene Abeparvovec for Broader SMA Population

November 25th 2025
Article

Onasemnogene abeparvovec-brve is now the first gene replacement therapy approved for spinal muscular atrophy in patients 2 years and older.

Read More

AJMC Q&A with Svetlana Barbarash | Background image credit: ipopba – stock.adobe.com

Women’s Subtle Arrhythmia Symptoms Are Often Overlooked: Svetlana Barbarash, MD

November 24th 2025
Article

Svetlana Barbarash, MD, explains how better education, digital monitoring tools, and coordinated care can improve arrhythmia detection and outcomes.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.